CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 3,076 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03709602
NCT03709602N/ACompleted

Social Determinants of HPV Vaccine Completion Among Adolescents

Duke University·observational·Posted Oct 17, 2018·Updated Sep 1, 2020

In Brief

An observational study for Human Papilloma Virus. Completed, enrolled 3,076 participants across 1 site.

Detailed Summary

The purpose of this research study is to find out which factors influence parents' ability to complete the human papillomavirus (HPV) vaccine series for their child. The information learned from this study may help the investigators develop programs to improve HPV vaccine completion rates among adolescents and reduce barriers to receiving the second shot of the vaccine series.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedOct 17, 2018
Enrollment StartJan 7, 2019
Primary CompletionDec 17, 2019
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 7.7 years ago